HT
INO icon

HAP Trading’s Inovio Pharmaceuticals INO Stock Holding History

HAP Trading’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,083
Closed -$174K – 2498
2021
Q4 		$174K Buy
3,083
+533
+21% +$42.7K ﹤0.01% 1064
2021
Q3 		$122K Sell
2,550
-9,642
-79% -$968K ﹤0.01% 1198
2021
Q2 		$141K Buy
12,192
+6,950
+133% +$668K ﹤0.01% 1107
2021
Q1 		$203K Buy
5,242
+500
+11% +$65.8K 0.01% 766
2020
Q4 		$223K Sell
4,742
-5,975
-56% -$795K 0.01% 920
2020
Q3 		$401K Buy
10,717
+1,742
+19% +$363K 0.02% 455
2020
Q2 		$152K Buy
8,975
+8,025
+845% +$1.29M 0.01% 758
2020
Q1 		$5K Buy
+950
New +$58.6K ﹤0.01% 1090
2018
Q2 		– Sell
-858
Closed -$14K – 1056
2018
Q1 		$14K Sell
858
-17
-2% -$920 ﹤0.01% 801
2017
Q4 		$21K Buy
+875
New +$54.2K ﹤0.01% 780

Other funds holding INO

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HAP Trading's INO Position: Q4 2021 in Review

HAP Trading sold out of Inovio Pharmaceuticals (INO) in Q4 2021, closing a stake of 2,915 shares — an estimated $234K sold.

HAP Trading first reported a position in INO in Q1 2021 and held it in 2 quarters. The position peaked at $250K in Q3 2021. 208 funds tracked by Wall St. Rank hold INO as of Q4 2021.

  • HAP Trading reported no remaining Inovio Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • HAP Trading sold 2,915 Inovio Pharmaceuticals shares in Q4 2021, an estimated $234K.
  • HAP Trading first reported a position in Inovio Pharmaceuticals in Q1 2021 and held it in 2 quarters.
  • HAP Trading's Inovio Pharmaceuticals position peaked at $250K in Q3 2021.
  • 208 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q4 2021.

Based on HAP Trading's 13F filing for Q4 2021, filed 14 Feb 2022.